Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.

Chen, Ping; Yu, Min; Zhang, Ji-Liang; Chen, Wei-Yong; Zhu, Li; Song, Yue; Jiang, Cheng-Yi; Zhang, Shuang.

Afiliação

Chen P; Department of Oncology, Chengdu Seventh People's Hospital, Chengdu Tumor Hospital, Chengdu 610041, Sichuan Province, China.
Yu M; Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Zhang JL; Department of Oncology, Chengdu Seventh People's Hospital, Chengdu Tumor Hospital, Chengdu 610041, Sichuan Province, China.
Chen WY; Department of Oncology, Chengdu Seventh People's Hospital, Chengdu Tumor Hospital, Chengdu 610041, Sichuan Province, China.
Zhu L; Department of Oncology, Chengdu Seventh People's Hospital, Chengdu Tumor Hospital, Chengdu 610041, Sichuan Province, China.
Song Y; Department of Oncology, Chengdu Seventh People's Hospital, Chengdu Tumor Hospital, Chengdu 610041, Sichuan Province, China.
Jiang CY; Department of Oncology, Chengdu Seventh People's Hospital, Chengdu Tumor Hospital, Chengdu 610041, Sichuan Province, China.
Zhang S; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China. shuangscu@126.com.

World J Clin Cases ; 8(13): 2876-2884, 2020 Jul 06.

Article em En | MEDLINE | ID: mdl-32742998